Wat is de prijs voor Novogene Co., Ltd. (688315)

Het prijs van Novogene Co., Ltd. (688315) is $2.25

Wat is de marktkapitalisatie voor Novogene Co., Ltd. (688315)

Marktkapitalisatie voorNovogene Co., Ltd. (688315) is $936.66M

Novogene Co., Ltd. (688315) Operationele Marge

Novogene Co., Ltd. is a global provider of comprehensive genomic services and advanced solutions. Its offerings span a wide array of genomic applications, including human, animal, plant, and microbial genome sequencing, alongside gene regulation and single-cell sequencing technologies. The company also specializes in cancer genomic profiling, whole exome sequencing (including clinical-grade versions), and FFPE RNA sequencing. Furthermore, Novogene develops proprietary tools such as NovoFocus, a next-generation sequencing (NGS)-based companion diagnostic for PARP inhibitor treatments, and NovoNeoantigen, a bioinformatics pipeline that identifies cancer neoantigens by analyzing whole exome and whole transcriptome sequencing data from matched tumor and normal samples. In a strategic collaboration, Novogene partners with Hummingbird Bioscience Pte. Ltd. to aid in the advancement of HMBD-001. This investigational anti-HER3 antibody is being assessed for its potential to treat diverse cancer types, notably those driven by NRG1-fusion. Established in 2011, Novogene Co., Ltd. operates from its headquarters in Beijing, China.

Jaar	Operationele Marge	Wijzigen
Niet genoeg gegevens voor de verstrekte datums.

Jaar

Operationele Marge

Wijzigen

Niet genoeg gegevens voor de verstrekte datums.

Bedrijf	Operationele Marge	Verschil in operationele marge	Land
Vertex Pharmaceuticals Incorporated VRTX.US	38.59%	-	US
Argenx SE ARGX.US	28.81%	-	NL
CSL Limited CSL.AX	25.72%	-	AU
Moderna, Inc. MRNA.US	-149.01%	-	US
Lonza Group AG LONN.SW	0.00%	-	CH

Bedrijf

Operationele Marge

Verschil in operationele marge

Land